| mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
8e-07 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
5e-06 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
26 |
6e-05 |
| mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
7e-05 |
| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
7e-05 |